NCT03173781View on ClinicalTrials.gov

Effects of Droxidopa When Measuring Gait Speed, Kyphosis, and Functional Reach in Parkinson's Disease

NACompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

October 31, 2017

Study Completion Date

October 31, 2017

Conditions
Parkinson's Disease
Interventions
DRUG

droxidopa

medication

DRUG

Placebo

medication

Trial Locations (1)

80907

Colorado Springs Neurological Associates, Colorado Springs

All Listed Sponsors
collaborator

H. Lundbeck A/S

INDUSTRY

lead

Colorado Springs Neurological Associates

OTHER

NCT03173781 - Effects of Droxidopa When Measuring Gait Speed, Kyphosis, and Functional Reach in Parkinson's Disease | Biotech Hunter | Biotech Hunter